Company overview
PolyPid Ltd., a clinical-stage biopharmaceutical company, developing targeted, locally administered, and prolonged-release therapeutics using its proprietary polymer-lipid encapsulation matrix (PLEX) technology to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in a pivotal Phase 3 confirmatory trial for prevention of surgical site infections (SSIs) in patients undergoing abdominal colorectal surgery with large incisions. It is also developing OncoPLEX, which is in preclinical stage for the treatment of intra-tumoral cancer. The company has a research and development collaboration with ImmunoGenesis, Inc. for the development of formulations to treat solid tumors. PolyPid Ltd. was incorporated in 2008 and is headquartered in Petah Tikva, Israel.
Daily valuation snapshot
These values come from the daily market snapshot dated 2026-10-08. TTM means trailing twelve months. Use the market date when comparing PYPD with another company.
| Daily close (USD) | $4.9 |
| Market capitalization (USD) | $99,527,653.4 |
| Price / earnings (TTM) | Not reported |
| Price / book | 9.07 |
No matching rows. Clear the filter to see all records.
Read PYPD's valuation metrics
Company size
PolyPid Ltd. Ordinary Shares's recorded market capitalization is $99,527,653.4. It measures the market value of the company's equity, rather than its revenue or cash balance.
Price relative to earnings
P/E compares share price with trailing annual earnings per share. For a company with losses, inspect the earnings figures directly rather than treating a negative multiple as a cheap valuation.
Price relative to book equity
PYPD's recorded price-to-book ratio is 9.07. That compares its market equity value with recorded book equity. Examine its business and balance sheet to understand why those values differ.
Research PolyPid Ltd. Ordinary Shares with Aurora
Use the snapshot above to ask a specific question about PYPD. Ask for the report period and the figures behind the explanation, then compare the answer with the company's business description.
Continue the research
Follow PYPD's ownership disclosures to see who filed a transaction or position and when it became public. To turn a research idea into a strategy, define an entry rule and test its dated observations.